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Abstract
AIM: To assess a relationship between longitudinal 
changes in liver fat content and biochemical parameters 
in obese children after 1-year nutritional intervention.
METHODS: Forty-six obese children, 21 males and 25 
females, aged 6-14 years, underwent metabolic meas-
urements, liver ultrasonography (US) and chemical-
shift magnetic resonance imaging (MRI) examinations 
at baseline and after 1-year nutritional intervention. A 
child was defined obese if her/his body mass index (BMI) 
was above the age- and sex-adjusted BMI Cole’s curve 
passing through the cut-off of 30 kg/m2 at 18 years. 
BMI Z  scores were calculated and adjusted for age and 
gender by using the Cole’s LMS-method and Italian 
reference data. Biochemistry included serum alanine 
aminotransferase (ALT) and aspartate aminotrans-
ferase (AST). Abdominal US and chemical-shift MRI 
were performed according to a randomized sequence. 
The same radiologist performed US by a GE Logiq 9 
(General Electric Healthcare Medical Systems, Milwau-
kee, WI, United States) using a 3.5-MHz convex array 
transducer. Liver echogenicity was evaluated independ-
ently on videotape by 3 radiologists unaware of the 
child and MRI outcomes, and a consensus was estab-
lished. Another experienced radiologist, unaware of the 
child and US data, performed the abdominal chemical-
shift MRI with a 1-t system NT-Intera (Philips Medical 
Systems, Best, The Netherlands) and a phased-array 
coil. Liver fat fraction (FF) on MRI was judged elevated 
when greater than 9%. A FF > 18% was considered 
expressing more severe cases of fatty liver according 
to Fishbein. A nutritional-behavioral intervention was 
recommended to promote a normocaloric balanced diet 
and active lifestyle based on the Italian guidelines for 
treatment of childhood obesity.
RESULTS: Compared to baseline, at the end of inter-
vention children showed lower intakes of energy (mean 
± SD: 2549 ± 1238 Kcal vs  1770 ± 622 Kcal, P  < 
0.0001), total fat (90 ± 47 g vs  52 ± 23 g, P  < 0.0001), 
carbohydrates (356 ± 174 g vs  241 ± 111 g, P  = 0.001), 
and protein (99 ± 48 g vs  75 ± 23 g, P  = 0.006) in-
takes. Prevalence of FF ≥ 9% declined from 34.8% 
to 8.7% (P  < 0.01), with a mean reduction of 7.8% 
(95%CI: 5.0-10.6). At baseline, FF was associated with 
liver biochemical parameters (maximum P  < 0.001). At 
the end of the intervention association was found with 
AST (P  = 0.017). Change of FF was associated with 
change in AST (P  = 0.027) and ALT (P  = 0.024). Rate 
of increased liver echogenicity declined from 45.6% to 
21.7% (P  < 0.0001). Liver echogenicity was associated 
with ALT at baseline only (P  < 0.001). An age- and sex- 
adjusted multiple regression analysis showed that FF 
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change was independently associated with change in 
serum AST (adjusted regression coefficient 0.348, P = 
0.048).
CONCLUSION: The results suggest that in obese chil-
dren longitudinal changes in liver fat content based on 
MRI may be associated with change in serum transami-
nases suggesting novelty in monitoring nonalcoholic 
fatty liver disease.
© 2013 Baishideng. All rights reserved.
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Core tip: In our study we demonstrate that in obese 
children longitudinal change in liver fat content evalu-
ated on magnetic resonance imaging is associated with 
change in serum transaminases and more weakly also 
with changes in triglyceridemia and apolipoproteins, af-
ter a nutritional intervention based on normocaloric bal-
anced diet. Furthemore this is the first study purposely 
designed to evaluate in obese children whether any re-
lationship may exist of longitudinal changes in liver fat 
content with changes in liver biochemical parameters 
These findings may suggest novelty in clinical monitor-
ing nonalcoholic fatty liver disease severity in childhood 
obesity.
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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) ranges from 
fat in the liver to advanced fibrosis and cirrhosis[1]. Obes-
ity is a condition frequently associated with NAFLD 
both in children and adults[1-3]. The overall prevalence of  
fatty liver based on histological diagnosis in the pediat-
ric population has been estimated to be around 13%[1]. 
The highest rate of  fatty liver was seen in obese children 
(32%-50%)[4,5]. In children, NAFLD is becoming more 
frequently diagnosed with increasing in rates of  obes-
ity[5,6], and might indicate a possible metabolic outcome 
of  obesity[5]. Therefore, accurate diagnosis of  disease as 
well monitoring of  the patients over time remains a ma-
jor challenge for pediatricians taking care of  the growing 
number of  children with NAFLD[7]. Liver biopsy is the 
gold standard for establishing diagnosis and severity of  
NAFLD but it may not be done repeatedly in children. 
Accordingly, non invasive approaches are important for 
the clinician. Ultrasonography (US) and chemical-shift 
magnetic resonance imaging (MRI), fast to perform, 
may be useful to detect liver fat content and monitor-
ing NAFLD[8-14]. On US, fatty liver produces a diffuse 
increased echogenicity with posterior beam attenuation[8]. 
MRI is able to quantify the fat content accurately and 
identify changes over time in children with NAFLD[9-15]. 
Indeed, studies proved that assessment by MRI agrees 
better than US with the diagnosis of  steatosis based on 
biopsy[10,12-14]. While, it is still debatable whether in obese 
children US may be valuable in identifying high hepatic 
fat accumulation[8], it may show poor ability in identifying 
lower fat content compared with MRI[9,12,13]. 
Children with NAFLD are usually asymptomatic and 
come to clinical attention because of  elevated liver en-
zymes or fatty liver seen in incidentally observed elevated 
serum aminotransferases[6]. While concordance between 
serum aminotransferases and US in identifying fatty liv-
er[12,16,17] may be low, it has been proved for MRI[12,18]. De-
spite the potential clinical and practical relevance, there is 
lack of  studies in the current literature assessing the rela-
tionship of  longitudinal change of  liver fat content with 
liver biochemical parameters in pediatric age.
The aim of  the present study was to assess whether 
any association may exist of  longitudinal changes in liver 
fat content with change in liver biochemical parameters 
in obese children who underwent a 1-year nutritional in-
tervention.
MATERIALS AND METHODS
Fifty children, aged 6-14 years, were consecutively recruit-
ed at the Pediatric Department of  the San Paolo Hospi-
tal, Milan, Italy, between July 1, 2010 and June 31, 2012 
according to the following eligibility criteria. Inclusion 
criteria were: age > 6 years, obesity, and white parents. 
Exclusion criteria were: having syndromic, organic and 
hormonal conditions besides obesity that may predispose 
to liver disease, including infectious hepatitis B and C, 
alpha-1-antitrypsin deficiency, medications affecting liver 
metabolism, diabetes, any alcohol consumption. Children 
aged < 6 years were not included as it may be difficult to 
perform accurately MRI for lack of  compliance. Obesity 
was defined according to the International Obesity Task 
Force[19].
The parents of  eligible children or their legal guard-
ian received detailed explanation about the aim of  the 
study, and signed a consent form. The Hospital Ethics 
Committee approved the study protocol and gave ethical 
clearance. 
Anthropometric measurements, nutritional and meta-
bolic examinations, US and MRI assessments were per-
formed within 3 ± 1 d before starting intervention (base-
line) and one year (± 5 d) after (end of  intervention).
Anthropometry and clinical data
Anthropometrical evaluation included measurements 
of  weight and height. The body mass index (BMI) was 
calculated from the ratio of  weight to height2 (kg/m2). 
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A child was defined obese if  her/his BMI was above the 
age- and sex-adjusted BMI Cole’s curve passing through 
the cut-off  of  30 kg/m2 at 18 years[19]. BMI Z scores 
were calculated and adjusted for age and gender by using 
the Cole’s LMS-method[20] and Italian reference data[21]. 
A medical history was additionally collected at baseline 
from parents by a standardized questionnaire at a per-
sonal interview conducted by the same pediatrician.
Biochemistry
Fasting blood samples were taken at 8 h ± 30 min am 
Flavoured glucose at a dose of  1.75 g/kg body weight 
(up to a maximum of  75 g) was then given orally, and ad-
ditional blood samples were taken for measurements of  
plasma glucose at 120 min. Blood samples were collected 
and analysed immediately at the Hospital Department 
of  Biochemistry. Total cholesterol (TC), high-density-
lipoprotein cholesterol (HDL-C) and triacylglycerol (TG) 
plasma levels were measured using a dry multiplayer 
enzymatic method (Ectachem DT-60; Eastman Kodak 
Co., Rochester, NY). Low-density-lipoprotein choles-
terol (LDL-C) serum levels were calculated according 
to the Friedewald formula [LDL-C = TC - (HDL-C + 
TG/5)][22]. Apolipoprotein A1 and Apolipoprotein B 
were measured using a Modular analyzer (BNII, Dade 
Behring; Marburg, Germany). Alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), and gamma 
glutamyltransferase (γGT) were measured by a Hitachi 
917 Analyzer and Roche Diagnostics reagents (both Man-
nheim, Germany).
Abdominal US and chemical-shift MRI
Abdominal US and chemical-shift MRI were performed 
according to a randomized sequence. The same radi-
ologist (AR) performed US by a GE Logiq 9 (General 
Electric Healthcare Medical Systems, Milwaukee, WI, 
United States) using a 3.5 MHz convex array transducer. 
Liver echogenicity was evaluated independently on vide-
otape by 3 radiologists unaware of  the child and MRI 
outcomes, and a consensus was established. Absolute 
agreement among judgments before discussion occurred 
in 94% of  cases at baseline, and in 93.5% of  cases at the 
end of  intervention. Echogenicity was graded as follows: 
grade 0, normal echogenicity; grade 1, slight increase in 
liver echogenicity, slight exaggeration of  liver and kidney 
echo discrepancy, and relative preservation of  echoes 
from the walls of  the portal vein; grade 2, loss of  echoes 
from the walls of  the portal veins, particularly from the 
peripheral branches, greater posterior beam attenuation, 
and greater discrepancy between hepatic and renal ech-
oes; grade 3, greater reduction in beam penetration, loss 
of  echoes from most of  the portal vein wall, including 
the main branches, and large discrepancy between hepatic 
and renal echoes[23].
Another experienced radiologist (CP), unaware of  the 
child and US data, performed the abdominal chemical-
shift MRI with a 1-T system NT-Intera (Philips Medical 
Systems, Best, The Netherlands) and a phased-array coil. 
For each child, axial T1-weighted gradient echo images 
both in-phase [15/6.90 (repetition time msec/echo time 
msec), flip angle of  25°] and out-of-phase [15/3.45 (rep-
etition time msec/echo time msec), flip angle of  25°] 
were obtained. The echo time is the time from the appli-
cation of  the radio frequency pulse to peak of  the signal. 
Section thickness was 10 mm, field of  view was 375 mm, 
and matrix was 256 pixels. Scan duration was 1 m/23 
s for each in-phase or out-of-phase image. Respiratory 
compensation was used (scan duration for respiration, 
1.6 s). Twenty contiguous transverse images in-phase and 
out-of-phase were obtained. Two operators not involved 
in the study and unaware of  the patient’s disease inde-
pendently selected the slice showing the best evidence of  
liver parenchyma to be considered for examination and 
the region of  interest (ROI). Three ROI with the same 
area (80-100 mm2) were drawn on the corresponding in-
phase and out-of-phase images. Two regions were drawn 
in the right liver, one in the left liver. For each region, the 
signal intensity was measured on both in-phase and out-
of-phase images and the mean pixel signal intensity data 
were recorded for further calculation. The liver fat frac-
tion (FF) was calculated from the mean pixel signal inten-
sity data using the formula: FF = [SI (in-phase) - SI (out-
of-phase)]/2SI (in-phase). The hepatic FF was considered 
to be normal at a value less than 9% and non-normal as 
FF ≥ 9%[10,11]. A FF > 18% was considered expressing 
more severe cases of  fatty liver according to Fishbein[24]. 
Additionally the cut off  of  5% for FF was used accord-
ing to studies conducted on obese children, e.g. [14]. 
Nutritional-behavioral intervention and dietary habits
A nutritional-behavioral intervention was recommended 
to promote a normocaloric balanced diet and active 
lifestyle based on the Italian guidelines for treatment of  
childhood obesity[25]. Diet was normocaloric (daily caloric 
intake by sex and age) and consisted of  carbohydrate 
(55%-60%, < 10% high glycemic index carbohydrate), 
fat (25%-30%, < 10% saturated fatty acids, polyunsatu-
rated up to 10%, monounsaturated up to 15%), protein 
(12%-15%), fiber [range: age (year) plus 5 - age (year) plus 
10, g][25]. Children and parents or the legal guardians un-
derwent 1-h nutritional counselling by the same experi-
enced dietician. Written guidelines were given to the par-
ents and children, including general nutritional advices, 
food choice lists, selected week-menu, recommended av-
erage servings for principal food categories according to 
age and sex. Additionally, recommendations were given 
to engage in a moderate daily exercise program (30-45 
min/d aerobic physical exercise), tailored to individual 
preferences. Dietary habits of  children were assessed at 
baseline and at the end of  intervention by means of  an 
age-adjusted Food Frequency Questionnaire (FFQ) made 
up of  116 items and designed according to Block[26]. The 
same experienced dietician, unaware of  the obesity status 
of  children, interviewed mothers for approximately 50 
min and each meal was analyzed to find out which food 
was eaten and how often. Usual portion sizes were esti-
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mated using household measures, the weight of  purchase 
(e.g., pasta) or unit (e.g., fruit juice). A 24-h recall on the 
day prior to the hospital admission was further recorded 
at the end of  the interview to standardize the usual serv-
ing size.
Medical examinations were scheduled every 3 mo 
during the intervention period. At each visit, parents of  
children or their legal guardians filled out a FFQ and 
physical activity recall to evaluate adherence to lifestyle 
recommendations. Quantification and analysis of  the 
energy intake and nutrient composition were performed 
with an ad hoc PC software program developed at our 
department and based on the Food and Nutrient Data 
Base issued by the National Institute of  Nutrition[27].
Sample size
The sample size was determined to detect a minimum 
effect size of  0.5 for a correlation between change in FF 
and change in liver biochemical parameters. Admitting a 
type Ⅰ error level of  0.05 with a power of  95%, and al-
lowing for a drop out up to 10%, 43 children needed to 
be recruited.
Statistical analysis
Data are expressed as mean (SD) and median or number 
of  observations (percentage). Intra-subject comparisons 
were performed by the Student’s t test for paired data 
or the Wilcoxon test, as appropriate. The association of  
liver fat fraction with BMI Z score, lipid profile, serum 
aminotransferases and gamma glutamyltransferase was 
assessed by Spearman’s correlation coefficient. When fat 
fraction was dichotomized (cut off  9%) Student’s t test 
for unpaired data or the Mann-Whitney U test were used. 
A multiple adjusted stepwise regression model was fitted 
for change of  FF, including as covariates change in liver 
biochemical parameters and lipid profile, and additional 
potential confounders (age, sex, duration of  obesity, 
change in BMI Z score). All values of  P < 0.05 were con-
sidered to indicate statistical significance (two-tailed test). 
The statistical package For social sciences (SPSS) package 
version 19.0 for Windows (SPSS, Chicago, IL) was used 
for the statistical analysis. 
RESULTS
Forty-six children (92%), 21 males and 25 females, com-
pleted the intervention and had all US, MRI and blood 
tests performed. No difference was observed among 
children who completed the study or not, for any variable 
at baseline (minimum P > 0.130). No focal liver lesions 
were observed in any child. At recruitment, mean (SD; 
median) of  age, duration of  obesity was, respectively, 
10.1 (2.4; 10.0) years, 4.4 (2.8; 3.4) years. Plasma glucose 
was 868 (6.3; 86.0) mg/L at fasting and 993 (17.3; 99.5) 
mg/L at 120 min at baseline, and 856 (6.6; 85.0) mg/L at 
fasting and 977 (14.2; 98.0) mg/L at 120 min at the end. 
Compared to baseline at the end of  intervention children 
showed lower intakes of  energy (mean ± SD: 2549 ± 
1238 Kcal vs 1770 ± 622 Kcal, P < 0.0001), total fat (90 
± 47 g vs 52 ± 23 g, P < 0.0001), carbohydrates (356 ± 
174 g vs 241 ± 111 g, P = 0.001), and protein (99 ± 48 g 
vs 75 ± 23 g, P = 0.006) intakes. Children spent 2.3 h (1.6 
h)/d of  physical activity at baseline and 2.8 h (1.8 h)/d at 
the end of  intervention (P = 0.174).
Table 1 reports the main characteristics and clinical, 
liver and lipid profile. After intervention there was a re-
duction in BMI Z score (mean reduction 0.32, 95%CI: 
0.21-0.43), triglycerides (0.33, 0.15-0.50) mmol/L, ALT 
(11.1, 5.6-16.5) mg/dL, AST (4.8, 2.1-7.4) mg/dL, γGT 
(2.5, 1.5-3.6) U/L and apolipoprotein B (7.2, 1.1-13.2) 
mg/dL. Rate of  increased liver echogenicity declined 
from 45.6% to 21.7% (P < 0.0001). On MRI, rate of  liver 
FF ≥ 9% declined from 34.8% to 8.7% (P < 0.001), and 
from 45.7% to 10.97% (P < 0.001) at cut off  of  5% for 
FF, with a mean FF (95%CI) reduction of  7.8 (5.0-10.6)%. 
In children who exhibited FF ≥ 9% at baseline (n = 16) 
(maximum FF 43%), FF declined from a (mean ± SD: 
22.6% ± 11.5% vs 6.2% ± 10.5%, P < 0.0001), and in 12 
was lower than 9%.
At baseline fat fraction was associated with liver bio-
chemical parameters, while at the end of  intervention 
association was found of  FF with transaminases. Change 
of  FF was associated with changes in AST and ALT. 
  Variable Baseline
(n  = 46)
End of 
intervention
(n = 46)
1P  value
  BMI Z score     2.3 (0.4); 2.1 1.90 (0.6); 1.9 < 0.001
  Fat fraction (%)     7.8 (13.3) 0.01 (8.3) < 0.001
     FF ≥ 5%       21 (45.7)      5 (10.9) < 0.001
     FF ≥ 9%      16 (34.8)      4 (8.7) < 0.001
  Liver echogenicity (%)
     0      25 (54.3)    36 (78.3)   < 0.0001
     1      14 (30.4)      9 (19.6)
     2        6 (13.0)      1 (2.2)
     3        1 (2.2)      0 (0.0)
  ALT (UI/L)   34.8 (12.0); 29.0 23.8 (8.70); 22.50 < 0.001
  AST (UI/L)   30.7 (10.1); 29.0 25.9 (7.50); 26.00 < 0.001
  γGT (UI/L)   15.7 (5.2); 15.0 13.1 (3.80); 12.00 < 0.001
  Total cholesterol (mmol/L)   4.39 (0.70); 4.48 4.30 (0.76); 4.23    0.211
  HDL cholesterol (mmol/L)   1.22 (0.24); 1.23 1.21 (0.22); 1.24    0.916
  LDL cholesterol (mmol/L)   2.64 (0.59); 2.60 2.60 (0.67); 2.56    0.306
  Triglycerides (mmol/L)   1.31 (0.62); 1.20 0.99 (0.46); 0.94 < 0.001
  Apo A1 (g/L)   1.24 (0.21); 1.21 1.28 (0.21); 1.26    0.122
  Apo B (g/L)   0.73 (0.17); 0.70 0.66 (0.15); 0.67    0.022
Table 1  Body mass index -z  score, fat fraction, liver 
echogenicity, liver biochemical parameters and lipid profile 
of the studied population at baseline and at the end of 
intervention, values are mean (SD)+ and median or number 
of observation (%)
1Adjusted for age, sex and duration of obesity; 2Student’s t test for paired 
data or Wilcoxon signed-rank test. Normal range[32]: ALT (5-45 UI/L) for 
age 1-19 years; AST (15-55 UI/L) for age 1-9 years and (5-45 UI/L) for age 
10-19 years; gammaGT (5-32 U/I) for age 4 mo-9 years and (5-24 UI/L) for 
age 10-15 years. SI convertion factors: to convert cholesterol, divide values 
by 0.0259; to convert triglycerides, divide values by 0.0113; to convert Apo 
A1 and Apo B values by 0.01. BMI: Body mass index; FF: Fat fraction; ALT: 
Alanine aminotransferase; AST: Aspartate aminotransferase; γGT: Gamma 
glutamyltransferase; HDL: High-density-lipoprotein; LDL: Low-density-
lipoprotein.
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Liver echogenicity was associated with ALT at baseline 
only (Table 2). Fat fraction was also associated with trig-
lycerides (Spearman correlation coefficient, r baseline, r 
= 0.516, P < 0.0001; end of  intervention, r = 0.329, P = 
0.031; change, r = 0.517, P < 0.0001) and Apo B (baseline, 
r = 0.391, P = 0.008; change, r = 0.398, P = 0.024), but 
not with cholesterol or Apo A1 (minimum P = 0.114). 
No association of  liver echogenicity was found with trig-
lycerides or cholesterol or apolipoproteins (minimum P 
= 0.063). No association of  BMI Z score was found with 
FF or liver echogenicity (minimum P = 0.517).
An age and sex adjusted multiple stepwise regression 
model showed that FF change was independently and 
positively associated with serum AST level change (ad-
justed regression coefficient 0.348, P = 0.048).
Moreover at baseline acanthosis nigricans, a skin 
features associated to hyperinsulinemia, was present in 
15.4% of  the evaluated children and decline to 10.1% af-
ter intervention.
Lastly, Table 3 compares liver biochemical and lipid 
profile when considering the FF dichotomized at 9%. 
At baseline aminotransferases, γGT and triglycerides 
were higher in children with liver FF ≥ 9%. At the end 
of  intervention, aminotransferases and total cholesterol 
levels were higher in children with FF ≥ 9%. Mean dif-
ference (95%CI) of  BMI Z score and duration of  obesity 
between children with FF ≥ 9% vs FF < 9% was respec-
tively 0.15 (-0.12; 0.42) and 1.1 (-0.69; 2.87), at baseline. 
Out of  16 children with FF ≥ 9%, 8 (50%) showed FF 
> 18%. Mean (SD) and median of  AST, ALT and γGT 
between children with FF > 18% vs 9% < FF < 18% was 
respectively 44.6 (12.7), 42.0 vs 31.9 (8.5), 29.0 (P = 0.035); 
63.6 (28.5), 55.0 vs 37.4 (22.7), 30.5 (P = 0.027); 20.2 (5.0), 
21.5 vs 16.1 (3.7), 16.0 (P = 0.063) at baseline. At base-
line only ALT values were elevated in children with FF 
> 18%. After intervention the ALT mean values ranged 
from 63.6 (28.5), 55 to 32.7 (14.2), 29.0 (P < 0.012), value 
that is in the normal range. In particular out of  children 
with FF > 18% (n = 8) 87.5% (n = 7) showed elevated 
ALT values and declined to 25% (n = 2) after interven-
tion. Similar results were found when considering a cut 
off  of  5% for FF.
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DISCUSSION
This is the first study purposely designed to evaluate in 
obese children whether any relationship may exist of  lon-
gitudinal changes in liver fat content with changes in liver 
biochemical parameters after a nutritional intervention 
based on normocaloric balanced diet. The study based 
assessment of  liver fat content on MRI, that has been 
recognized performing better than US for evaluation of  
liver fat[13] in the general population, as well in obese ado-
lescents[16] and children with NAFLD[14,15].
The overall prevalence of  elevated (≥ 9%) liver fat 
fraction at baseline was 34.8%, that is within the range 
(32%-40%) estimated in recent studies conducting in 
obese children and using MRI[4,14,15]. At the end of  in-
tervention, the liver FF declined in three-quarter of  
children, and was lower than 9% in 91.3% of  children 
with baseline FF ≥ 9%. Similar findings have been 
reported in other studies conducted in obese children 
with NAFLD[14,15]. In this study, children showed after 
intervention a decrease in BMI Z score of  13.9%, that 
may be not unexpected given the decline occurred in 
dietary intake. Others studies estimated at the end of  nu-
tritional interventions a BMI Z score reduction ranging 
from 12.7%[15] to about 40%[14]. It should be noted that 
the present study may not fully reflect across-country 
experience. Indeed even in the most successful weight 
control program for children in the US, the success rate 
of  weight loss may differ[28]. It cannot be excluded that 
genetic and environmental factors, different compliance 
to nutritional intervention may contribute, at least in part, 
to this difference. Therefore the results of  the present 
study should be contextualized.
Nonalcoholic fatty liver disease, as a component of  
the metabolic syndrome[1], is usually suggested by find-
ing elevated serum hepatobiliary enzymes (mostly ALT 
and GGT)[12,18,24]. Serum ALT activity is a widely available 
and inexpensive test for the screening and initial evalu-
ation of  NAFLD[29]. The sensitivity of  this biochemical 
marker, however, remains low because a number pediatric 
patients may present ALT values in the normal range[29]. 
Moreover, given the clinical relevance of  identifying 
children with steatohepatitis (NASH), several studies 
have described biomarkers associated with pediatric 
NASH[29,30]. Patton et al[30], evaluating clinical relation of  
histopathology with transaminases in pediatric NAFLD, 
found that AST was superior to ALT in distinguishing 
NAFLD patterns, while other studies showed ALT per-
forming better[12,15,24]. Indeed, it is now widely accepted 
that the degree of  ALT elevation does not correlate 
with the presence or severity of  histological findings of  
NAFLD[29]. For this reason in the present study we con-
sidered not only the transaminases value at baseline and 
at the end of  treatment but also the change.
In the present study obese children with FF ≥ 9% 
showed higher values of  aminotransferases than children 
with FF < 9% at baseline and at the end of  intervention. 
In particular AST mean values were within the normal 
range both at baseline and at the end of  intervention, 
AST ALT γGT
  Baseline
     Fat fraction    0.634 (< 0.0001)     0.456 (< 0.001)   0.469 (< 0.0001)
     Liver echogenicity 0.282 (0.0530)     0.437 (< 0.001)   0.232 (0.0750)
  End of treatment
     Fat fraction 0.351 (0.0170) 0.297 (0.056)   0.279 (0.0630)
     Liver echogenicity 0.260 (0.1030) 0.242 (0.070)   0.116 (0.2540)
  Change (end of treatment-baseline) 
     Fat fraction 0.326 (0.0270) 0.331 (0.024)   0.271 (0.0720)
     Liver echogenicity 0.225 (0.0820) 0.260 (0.063)   0.204 (0.1900)
Table 2  Spearman correlation coefficent (P  value) of fat 
fraction and liver echogenicity with liver function parameters 
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; γGT: 
Gamma glutamyltransferase.
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while ALT mean values was slight superior to the upper 
normal value at baseline but normal after one year of  in-
tervention. Similar results were found when considering a 
cut off  of  5% for FF.
However, considering more severe cases of  fatty liver 
(17.4%) ALT mean values were elevated and normal-
ized after the intervention. In particular the ALT values 
normalized in 62.5% of  children with FF > 18%. The 
association of  liver biochemical parameters with FF was 
stronger than with liver echogenicity both at baseline and 
the end of  intervention, in accordance with the litera-
ture[8,18]. Change in any liver biochemical parameter was 
not was associated with change in liver echogenicitys, 
supporting previous findings[8]. On the contrary, change 
in AST and ALT was associated with change in liver fat 
fraction. These results may be expected. Indeed as MRI 
may agree better than US with the diagnosis of  steatosis 
based on biopsy[10,12-14], MRI may be a reasonable way to 
follow liver fat in NAFLD.
Age and sex adjusted regression analysis showed that 
FF change was independently associated with change 
in serum AST level. This result could be of  clinical and 
practical relevance when monitoring NAFLD in child-
hood obesity and suggest that more research is neces-
sary to elucidate the liver serologic biomarkers and their 
changes through intervention with greatest sensitivity and 
specificity in predicting steatohepatitis. Additionally, it 
should be noted that at univariate analysis an association 
was found between change of  liver FF with change of  
triglyceridemia, and apolipoprotein B. Indeed, while as-
sociation with change in triglyceridemia may well reflect 
variation in hepatocyte accumulation of  triglycerides[3], 
hallmark of  NAFLD, association with Apo B, that repre-
sents non-high density lipoprotein cholesterol, including 
very-low density lipoprotein, may suggest the risk to de-
velop non-alcoholic steatohepatitis[31]. Additionally, longi-
tudinal studies support that NAFLD may be linked with 
increased risk of  cardiovascular disease, independently of  
classical atherosclerotic risk[1]. 
A limitation of  the present study is the absence of  
a control group of  obese children on free diet. Indeed, 
may be not fully agreement on ethnicity of  recruitment 
of  a such control group considering also that the lack 
of  interventions in the treatment of  childhood obesity 
would not met the current requirements of  the Italian 
Society of  Pediatrics[25]. A second limitation is that the 
gold standard to assess food intake is the 3 d food record, 
however the Frequency Food Questionnaire is largely 
used and in the present study was associated with a 24-h 
recall to standardize the usual serving size. A third limita-
tion is that this study did not plan assessment of  fat liver 
content by liver biopsy, that may be considered unethi-
cal in obese ‘‘healthy’’ children, and by proton magnetic 
resonance spectroscopy, a technique that may show high 
ability, as well MRI, for the evaluation of  hepatic steatosis 
in general population (Youden’s index ranging from 0.647 
to 0.842)[9,13], and additionally filters the signal fat-fraction 
from potential confounding technical and biological noises. 
On the whole, within the limitations of  this study, one 
may conclude that in obese children longitudinal change 
in liver fat content evaluated on MRI is associated with 
change in serum transaminases and more weakly also 
with changes in triglyceridemia and apolipoproteins, sug-
gesting novelty in clinical monitoring NAFLD severity in 
childhood obesity. 
Large longitudinal trials with adequate power are de-
siderable to better investigate the relationship of  longitu-
dinal variations of  liver fat content with serum liver and 
lipid profile, to elucidate the liver sierologic biomarkers 
and their changes with greatest sensitivity and specificity 
in predicting steatohepatitis and their clinical means in 
NAFLD management.
COMMENTS
Background
Children with nonalcoholic fatty liver disease (NAFLD) are usually asympto-
matic and come to clinical attention because of elevated liver enzymes or fatty 
liver seen in incidentally observed elevated serum aminotransferases. While 
concordance between serum aminotransferases and ultrasonography (US) in 
identifying fatty liver may be low, it has been proved for magnetic resonance 
Baseline (n = 46) 1P  value End of  intervention (n  = 46) 1P  value
FF < 9% (n  = 30) FF ≥ 9% (n  = 16) FF < 9% (n  = 42) FF ≥ 9% (n  = 4)
  2AST (UI/L)  26.70 (5.9);  26.00 38.20 (12.3); 40 0.001  29.10 (8.6); 28.50 34.70 (6.4); 33.00 0.015
  2ALT (UI/L) 26.50 (7.7); 25.00      50.50 (28.3); 48.50 0.001   30.50 (13.6); 29.00   40.70 (16.1); 40.50 0.015
  2γGT (UI/L) 14.40 (5.0); 13.00    18.20 (4.8); 17.50 0.018  15.40 (5.3); 14.50 16.00 (3.7); 15.50 0.092
  Triglycerides (mmol/L)   1.14 (0.44); 1.10      1.62 (0.80); 1.38 0.013    0.96 (0.44); 0.89   1.36 (0.45); 1.25 0.090
  Total cholesterol (mmol/L)   4.34 (0.69); 4.35      4.48 (0.74); 4.54 0.539    4.22 (0.73); 4.18   5.06 (0.62); 4.98 0.034
  HDL cholesterol (mmol/L)   1.23 (0.21); 1.24      1.20 (0.29); 1.17 0.716    1.21 (0.20); 1.24   1.23 (0.36); 1.21 0.950
  LDL cholesterol (mmol/L)   2.58 (0.61); 2.58      2.76 (0.56); 2.75 0.348    2.54 (0.63); 2.53   3.21 (0.75); 3.03 0.086
  Apo A (g/L)   1.21 (0.01); 1.23      1.29 (0.24); 1.20 0.259    1.29 (0.21); 1.27   1.12 (0.13); 1.12 0.199
  Apo B (g/L)   0.71 (0.18); 0.68       0.77 (0.15); 0. 70 0.261    0.65 (0.14); 0.02    0.85 (0.13); 0. 86 0.064
Table 3  Liver biochemical parameters and lipid profile of the studied population at baseline and at the end of 
intervention in relation to liver FF, dichotomized at 9%, alues are mean (SD)+ and median 
1Adjusted for age, sex, BMI Z score and duration of obesity; 2Significance of difference between FF groups (Student’s t test for unpaired data or the Mann-
Whitney U test). SI convertion factors: to convert cholesterol, divide values by 0.0259; to convert triglycerides, divide values by 0.0113; to convert Apo A1 
and Apo B values by 0.01. Normal range[32]: ALT [5-45 UI/L] for age 1-19 years; AST [15-55 UI/L] for age 1-9 years and [5-45 UI/L] for age 10-19 years; 
gammaGT [5-32 U/I] for age 4 mo-9 years and [5-24 UI/L] for age 10-15 years[32]. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; γGT: 
Gamma glutamyltransferase; HDL: High-density-lipoprotein; LDL: Low-density-lipoprotein.
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imaging (MRI). Despite the potential clinical and practical relevance, there is 
lack of studies in the current literature assessing the relationship of longitudinal 
change of liver fat content with liver biochemical parameters in pediatric age.
Research frontiers
Accurate diagnosis of disease as well monitoring of the patients over time 
remains a major challenge for pediatricians taking care of the growing number 
of children with NAFLD. The research hotspot is to elucidate the liver sierologic 
biomarkers and their changes with greatest sensitivity and specificity in predict-
ing steatohepatitis and their clinical means in NAFLD management.
Innovations and breakthroughs
While concordance between serum aminotransferases and US in identifying 
fatty liver may be low, it has been proved for MRI. Hovewer there is lack of 
studies in the current literature assessing the relationship of longitudinal change 
of liver fat content with liver biochemical parameters. This is the first study pur-
posely designed to evaluate in obese children whether any relationship may ex-
ist of longitudinal changes in liver fat content with changes in liver biochemical 
parameters after a nutritional intervention based on normocaloric balanced diet.
Applications
These results suggest that in obese children longitudinal change in liver fat 
content evaluated on MRI is associated with change in serum transaminases 
and more weakly also with changes in triglyceridemia and apolipoproteins, sug-
gesting novelty in clinical monitoring NAFLD severity in childhood obesity. 
Terminology
NAFLD ranges from fat in the liver to advanced fibrosis and cirrhosis. Obesity 
is a condition frequently associated with NAFLD both in children and adults US 
and chemical-shift MRI, fast to perform, may be useful to detect liver fat content 
and monitoring NAFLD. Studies proved that assessment by MRI agrees better 
than US with the diagnosis of steatosis based on biopsy.
Peer review
This is a very interesting study and a commendable piece of work analyzing the 
impact of a dietary intervention on liver fat content and biochemical parameters 
in obese children during a 1-year follow-up. The study provides solid evidence 
by means of metabolic measurements, liver ultrasonography and magnetic 
resonance imaging that a nutritional-behavioral intervention based on a normo-
caloric balanced diet and active lifestyle is useful in reducing fatty liver in obese 
children. Moreover the correlation between MRI and liver enzyme may be of 
practical value in NAFLD management in childhood.
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